Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | JNJJohnson & Johnson | LLYEli Lilly and Company |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | United States |
| Market cap | $676B | $1.3T |
| Price | $280.78 | $1432.29 |
| Last day | −0.47% | +1.44% |
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
JNJ analysis and Q-Scores →Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.